Cargando…
Bone morphogenetic protein signaling regulation of AMPK and PI3K in lung cancer cells and C. elegans
BACKGROUND: Bone morphogenetic protein (BMP) is a phylogenetically conserved signaling pathway required for development that is aberrantly expressed in several age-related diseases including cancer, Alzheimer’s disease, obesity, and cardiovascular disease. Aberrant BMP signaling in mice leads to obe...
Autores principales: | Vora, Mehul, Mondal, Arindam, Jia, Dongxuan, Gaddipati, Pranya, Akel, Moumen, Gilleran, John, Roberge, Jacques, Rongo, Christopher, Langenfeld, John |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9153151/ https://www.ncbi.nlm.nih.gov/pubmed/35641992 http://dx.doi.org/10.1186/s13578-022-00817-3 |
Ejemplares similares
-
Bone morphogenetic protein inhibitors and mitochondria targeting agents synergistically induce apoptosis-inducing factor (AIF) caspase-independent cell death in lung cancer cells
por: Mondal, Arindam, et al.
Publicado: (2022) -
Bone morphogenetic protein receptor 2 inhibition destabilizes microtubules promoting the activation of lysosomes and cell death of lung cancer cells
por: Mondal, Arindam, et al.
Publicado: (2021) -
Ym155 localizes to the mitochondria leading to mitochondria dysfunction and activation of AMPK that inhibits BMP signaling in lung cancer cells
por: Mondal, Arindam, et al.
Publicado: (2022) -
Targeting bone morphogenetic protein receptor 2 sensitizes lung cancer cells to TRAIL by increasing cytosolic Smac/DIABLO and the downregulation of X-linked inhibitor of apoptosis protein
por: NeMoyer, Rachel, et al.
Publicado: (2019) -
Inhibition of BMP and of TGFβ receptors downregulates expression of XIAP and TAK1 leading to lung cancer cell death
por: Augeri, Dave J., et al.
Publicado: (2016)